Pancreatic cancer is tough, but we’re taking it on. We’re here for people now, and funding research and campaigning to improve the future.
A diagnosis can be a terrible shock, but we’re here to help make sense of it and guide and support people every step of the way.
From cutting-edge tests to cancer-killing therapies, our scientists are striving for earlier detection and better treatment.
As a leading voice of the pancreatic cancer community, we work with governments, clinicians, researchers and those affected by the disease to find ways to speed up diagnosis, develop faster and better treatments – and call for more investment in research.
Everything you need to provide the best possible care for people with pancreatic cancer.
31 May 2026
Our comment on daraxonrasib results and the promising group of therapies known as KRAS inhibitors.
31 May 2026
A closer look at a promising group of treatments known as KRAS inhibitors these aim to treat cancers with a mutation in the KRAS gene.
20 May 2026
Help us build the biggest ever picture of pancreatic cancer care through our new pancreatic cancer registry.
31 May 2026
Our comment on daraxonrasib results and the promising group of therapies known as KRAS inhibitors.
31 May 2026
A closer look at a promising group of treatments known as KRAS inhibitors these aim to treat cancers with a mutation in the KRAS gene.
20 May 2026
Help us build the biggest ever picture of pancreatic cancer care through our new pancreatic cancer registry.
